Table 2.
Association of plasma Gal-3 levels with stroke outcomes.
| Ischemic stroke | |||||
|---|---|---|---|---|---|
| Dong et al. [46] | Outcome | Sensitivity | Specificity | Cut-off value | |
| Functional outcome | 88.4% | 76.9% | 53.5 pg/mL | ||
| Wang et al. [63] | Outcome | Q1∗ | Q2∗ | Q3∗ | Q4∗ |
| Death or major disability (OR) | 1.00 | 1.09 | 1.16 | 1.55 | |
| Death (OR) | 1.00 | 0.74 | 0.81 | 2.10 | |
| Major disability (OR) | 1.00 | 1.13 | 1.19 | 1.43 | |
| Haemorrhagic stroke | |||||
| Yan et al. ([64]) | 1-week mortality | 73.3% | 79.4% | 28.9 ng/mL | |
| 6-month mortality | 90.9% | 64.6% | 22.4 ng/mL | ||
| 6-month unfavourable outcome | 89.5% | 65.5% | 18.9 ng/mL | ||
| Liu et al. ([62]) | 6-month mortality | 77.8% | 70.6% | 24.6 ng/mL | |
| 6-month unfavourable outcome | 81.1% | 77.1% | 23.4 ng/mL | ||
∗Wang et al. categorized their study participants into 4 subgroups according to the quartiles of Gal-3 levels with Q4 being the highest quartile and Q1 being the lowest one. OR indicates odds ratio.